Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.000001 per share
-
Shares outstanding
-
139M
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
80M
-
Shares change
-
-16.4M
-
Total reported value, excl. options
-
$59.1M
-
Value change
-
+$9.53M
-
Number of buys
-
14
-
Number of sells
-
-10
-
Price
-
$0.74
Significant Holders of Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) as of Q2 2025
33 filings reported holding XTNT - Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share as of Q2 2025.
Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 80M shares
of 139M outstanding shares and own 57.41% of the company stock.
Largest 10 shareholders include Nantahala Capital Management, LLC (68.4M shares), AWM Investment Company, Inc. (6.6M shares), VANGUARD GROUP INC (2.25M shares), RENAISSANCE TECHNOLOGIES LLC (651K shares), GEODE CAPITAL MANAGEMENT, LLC (554K shares), Crescent Grove Advisors, LLC (412K shares), MILLENNIUM MANAGEMENT LLC (262K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (164K shares), Private Advisor Group, LLC (123K shares), and BlackRock, Inc. (120K shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.